Operating Expenses. 9.1. As used herein, the term “
Appears in 44 contracts
Samples: Lease (Fractyl Health, Inc.), Lease (Erasca, Inc.), Lease (Monte Rosa Therapeutics, Inc.)
Operating Expenses. 9.1. 9.1 As used herein, the term “
Appears in 12 contracts
Samples: Lease (Turnstone Biologics Corp.), Lease (Pyxis Oncology, Inc.), Lease (Cue Health Inc.)
Operating Expenses. 9.17.1. As used herein, the term “
Appears in 12 contracts
Samples: Sublease Agreement (Atara Biotherapeutics, Inc.), Lease (CareDx, Inc.), Lease (CareDx, Inc.)
Operating Expenses. 9.110.1. As used herein, the term “
Appears in 5 contracts
Samples: Lease (Ardelyx, Inc.), Lease (Ardelyx, Inc.), Lease (Revance Therapeutics, Inc.)
Operating Expenses. 9.18.1. As used herein, the term “
Appears in 3 contracts
Samples: Lease (Affymetrix Inc), Lease (Halozyme Therapeutics Inc), Lease (Halozyme Therapeutics Inc)
Operating Expenses. 9.1. 10.1 As used herein, the term “
Appears in 3 contracts
Samples: Lease (Tocagen Inc), Lease (Tocagen Inc), Lease (Tocagen Inc)
Operating Expenses. 9.1. 8.1 As used herein, the term “
Appears in 3 contracts
Samples: Lease (NanoString Technologies Inc), Lease (NanoString Technologies Inc), Lease (NanoString Technologies Inc)
Operating Expenses. 9.16.1. As used herein, (i) the term “
Appears in 1 contract
Samples: Lease (Qiagen Nv)
Operating Expenses. 9.16.1. As used herein, (i) the term “"
Appears in 1 contract
Samples: Digene Corp
Operating Expenses. 9.1. As used herein, the 10.1 The term “
Appears in 1 contract
Samples: Lease (Revance Therapeutics, Inc.)
